Standpoint Research Downgrades Teva Pharma (TEVA) to Hold
Get Alerts TEVA Hot Sheet
Price: $14.11 -2.22%
Rating Summary:
12 Buy, 25 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Rating Summary:
12 Buy, 25 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Join SI Premium – FREE
Standpoint Research downgraded Teva Pharma (NYSE: TEVA) from Buy to Hold.
For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.
Shares of Teva Pharma closed at $52.99 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Monness, Crespi, Hardt Downgrades Palantir Technologies Inc. (PLTR) to Sell on 'egregiously rich valuation... darkest days of this economic downturn are ahead of us'
- Raymond James Downgrades Extra Space Storage (EXR) to Outperform
- Compass Point Downgrades PebbleBrook Hotel Trust (PEB) to Neutral, 'could be several years before the company benefits fully from the significant investment over past years'
Create E-mail Alert Related Categories
DowngradesRelated Entities
Standpoint ResearchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!